- Home
- MASS vs DERM Comparison
MASS vs DERM Comparison
Compare MASS & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MASS | DERM |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.4M | 257.1M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MASS | DERM |
|---|---|---|
| Price | $6.88 | $8.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 265.4K | 82.7K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $59,631,000.00 | $56,134,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | $19.55 | $55.83 |
| P/E Ratio | $16.23 | ★ N/A |
| Revenue Growth | ★ 18.72 | N/A |
| 52 Week Low | $1.92 | $4.97 |
| 52 Week High | $9.34 | $9.56 |
Technical Indicators
Market Signals| Indicator | MASS | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 51.55 |
| Support Level | $6.19 | $6.71 |
| Resistance Level | $7.42 | $8.71 |
| Average True Range (ATR) | 0.37 | 0.48 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 74.19 | 57.68 |
Price Performance
Historical ComparisonAbout MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.